Dr. David Beversdorf was awarded one of the TRIUMPH (Translational Research Informing Useful and Meaningful Precision Health) grants through the University of Missouri. This is a $100,000 grant, and Dr. Beversdorf’s proposal was one of 30, from 88 submissions, that was selected.
His submission is entitled: Development of a multimodal imaging platform for precision medicine targeting in autism spectrum disorders
See more about the funding opportunity here: TRIUMPH Initiative – MU School of Medicine (missouri.edu)
Congratulations, Dr. Beversdorf!